CH

Clint Hermes

Advisor at RLS Therapeutics

Clint is an attorney with extensive experience with the regulation of human and animal research, clinical trial registration and transparency, conflicts of interest, federal grants, biospecimens, data sharing, and expanded access to investigational products. His work on behalf of the research missions of academic medical centers and life sciences companies has taken him throughout Africa, Asia, the Middle East, and South America. He has served on numerous Institutional Review Boards (IRBs) in the United States and abroad, including as Vice-Chair of a Harvard-affiliated IRB and of a biobank IRB abroad, and as a science policy advisor to a foreign government.

Clint has authored numerous articles and book chapters (including one published by Oxford University Press) in the areas of international health projects and biomedical research and has been quoted in publications such as MIT’s Technology Review, Bloomberg Law, Modern Healthcare, and Canada’s Globe and Mail

Timeline

  • Advisor

    Current role